It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Coxsackievirus A24 variant (CVA24v) is a major causative agent of acute hemorrhagic conjunctivitis outbreaks worldwide, yet the evolutionary and transmission dynamics of the virus remain unclear. To address this, we analyzed and compared the 3C and partial VP1 gene regions of CVA24v isolates obtained from five outbreaks in Cuba between 1986 and 2009 and strains isolated worldwide. Here we show that Cuban strains were homologous to those isolated in Africa, the Americas and Asia during the same time period. Two genotypes of CVA24v (GIII and GIV) were repeatedly introduced into Cuba and they arose about two years before the epidemic was detected. The two genotypes co-evolved with a population size that is stable over time. However, nucleotide substitution rates peaked during pandemics with 4.39 × 10−3 and 5.80 × 10−3 substitutions per site per year for the 3C and VP1 region, respectively. The phylogeographic analysis identified 25 and 19 viral transmission routes based on 3C and VP1 regions, respectively. Pandemic viruses usually originated in Asia, and both China and Brazil were the major hub for the global dispersal of the virus. Together, these data provide novel insight into the epidemiological dynamics of this virus and possibly other pandemic viruses.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Institute of Tropical Medicine “Pedro Kourí” (IPK), Virology Department, Center for Research, Diagnosis and Reference, Havana, Cuba (GRID:grid.419016.b) (ISNI:0000 0001 0443 4904)
2 Universidad de las Ciencias Informáticas (UCI), Departamento de Bioinformática, Centro de Matemática Computacional, Havana, Cuba (GRID:grid.441350.7) (ISNI:0000 0004 0386 287X)
3 Centro de Investigación Científica y de Educación Superior de Ensenada, Departamento de Ciencias de la Computación, Ensenada, México (GRID:grid.462226.6) (ISNI:0000 0000 9071 1447)
4 Institute of Tropical Medicine “Pedro Kourí” (IPK), Cell Culture Laboratory, Center for Research, Diagnosis and Reference, Havana, Cuba (GRID:grid.419016.b) (ISNI:0000 0001 0443 4904)
5 Havana University, Department of Microbiology and Virology, Biology Faculty, Havana, Cuba (GRID:grid.412165.5) (ISNI:0000 0004 0401 9462)
6 University of Gothenburg, Department of Infectious Diseases/Virology, Institute of Biomedicine, Sahlgrenska Academy, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582)
7 Lund University, Immunovirology Unit, Department of Clinical Sciences, Skåne University Hospital, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361)